Latest / The Demographics Podcast with Fexingo: Aging Populations, Birth Rates, and Economic Impact / How Falling Birth Rates Reshape the Insurance Industry
Transcript
- Lucas: So here's something that surprised me. Japan's life insurance premiums have dropped roughly 30 percent over the last decade. Not because of competition or regulation, but because there are simply fewer people in the age brackets that buy term life. Luna: Right, the classic demographic supply and demand story, but applied to insurance. And Japan is the canary in the coal mine for much of the developed world. Lucas: Exactly. And it's not just about fewer young customers. It's that the people who remain are older, which flips the whole risk pool. Term life insurance — where you pay a premium for a set period — becomes less attractive to a population that's thinking about retirement income, not protecting a mortgage. Luna: So insurers shift their product mix. I know in Japan, companies like Dai-ichi Life and Nippon Life have been aggressively pushing annuities and whole-life policies that serve as savings vehicles. Lucas: That's the pivot. Annuities are basically the mirror image of life insurance — instead of pooling risk against early death, you pool risk against living too long and outliving your savings. And that market is growing fast. The global annuity premium pool hit about $250 billion last year, with Japan accounting for maybe a fifth of that. Luna: And the underwriting changes, too. If you're selling a product where the payout is triggered by survival, not death, you start caring about different risk factors. Lucas: Exactly. For term life, you're worried about mortality risk — heart disease, accidents, cancer. For annuities, you're worried about longevity risk — will someone live to 95 and collect payments for thirty years? That requires different medical underwriting, different pricing models. Some Japanese insurers now offer lower annuity rates for people with chronic conditions, because their life expectancy is shorter. Luna: That feels a bit grim, but it's logical. The healthier you are, the longer the insurer expects to pay you, so your premium is higher. Lucas: Right. And this is where the demographic tailwind becomes a headwind for the industry. In a falling birth rate world, the traditional life insurance model — built on a broad base of young premium payers, with a smaller cohort of claims — starts to break down. The actuarial tables get tilted. Luna: So what does that mean for the big U.S. players, like MetLife or Prudential Financial? Lucas: Well, MetLife, for instance, has been shifting its focus away from pure life insurance for years. In their 2025 annual report, they noted that about 60 percent of their premiums now come from retirement and income solutions — group annuities, pension risk transfer — rather than traditional life. That's up from about 45 percent a decade ago. Luna: And that mirrors what we're seeing in Japan, just a few years behind. So the U.S. demographic curve is a slower-moving version of Japan's. Lucas: Yeah. The U.S. fertility rate is around 1.6 births per woman now, down from 2.1 in 2007. That means the pipeline of new life insurance customers is shrinking. Meanwhile, the over-65 population is growing at about 3 percent a year. So insurers that can pivot to longevity products are positioning themselves well. Luna: But there's a tension, right? If you're a shareholder in a life insurer, you're watching the core product line shrink. How do you maintain profitability? Lucas: That's the million-dollar question. One answer is pricing — if fewer people are buying term life, you can raise premiums on the ones who do, because the risk pool is smaller and more selected. But that can become a death spiral: higher prices drive away even more customers. Another answer is consolidation — we've seen a wave of M&A among Japanese life insurers, and I expect the same in the U.S. over the next five years. Luna: And then there's the investment side. Insurers are massive asset managers — they invest the premiums they collect. If the liability structure shifts from short-term death payouts to long-term annuity payouts, they need different asset-liability matching. Lucas: Right. A life insurer with a big annuity book needs to invest in longer-duration bonds to match those multi-decade payouts. That means more demand for 30-year Treasuries, less for corporate bonds. It actually has macro implications for the bond market. The Bank of Japan has noted that domestic insurers are among the largest buyers of super-long government bonds. Luna: And this is where the story gets broader than just one industry. The demographic shift is reshaping how capital flows through the economy. Lucas: If today was actually useful to you, the way these stay ad-free is listener support. Buy me a coffee dot com slash fexingo. Luna: Yeah, it's a small gesture that keeps us independent and means we don't have to run ads. We appreciate it. Lucas: So back to that bond market point. In Japan, insurers now hold about 30 percent of all outstanding government bonds with maturities over 20 years. That's a huge concentration. If interest rates rise, those bonds lose value, and insurers take a hit on their capital ratios. Luna: Which is exactly what happened when the Bank of Japan started normalizing rates in 2024 and 2025. Some smaller insurers had to raise capital. Lucas: Right. And that's a risk that's amplified by demographics. Because insurers are forced into long bonds by their product shift, they become more sensitive to rate changes. It's a structural vulnerability that didn't exist two decades ago. Luna: So what's the forward look? If birth rates keep falling, more countries will follow Japan's path. What does that mean for the insurance industry globally? Lucas: I think we'll see a bifurcation. In countries with still-growing populations, like India or parts of Africa, traditional life insurance has room to grow. In aging markets — Europe, East Asia, North America — the future is in longevity products, pension risk transfer, and maybe even new categories like longevity-linked bonds or mortality swaps. Luna: There's also the innovation angle. Some startups are using wearable data to offer dynamic annuity pricing — if your exercise data shows you're healthy, you get a better rate. It's a way to manage adverse selection. Lucas: That's fascinating. Because adverse selection is a huge problem in annuities — the people most likely to buy them are the ones who expect to live long, so the pool is already biased. Wearables could help insurers price that risk more accurately. Luna: Right. So insurers are moving from a world where they just take your age and gender, to one where they have a much richer picture of your health trajectory. Lucas: And that's a shift that mirrors what we've seen in auto insurance with telematics. But in life and annuity products, the stakes are higher and the time horizons longer. I think the next decade will see a wave of product innovation around longevity risk. Luna: One more thing — the regulatory angle. In the EU, Solvency II already requires insurers to hold more capital for long-tail liabilities. As more business shifts to annuities, that capital charge becomes more significant. Lucas: Yeah, and that can make annuity products more expensive, which reduces demand, which puts more pressure on insurers to find efficiencies. It's a cycle. But it also creates opportunities for reinsurers who can take on some of that longevity risk. Luna: So the bottom line: falling birth rates are forcing the insurance industry to reinvent itself. The old model of term life for young families is giving way to a new model focused on managing the risk of living long. Lucas: And that's a fundamental shift in how we think about insurance — from a product that protects against a bad outcome to one that helps you plan for a good outcome, if you define a long life as a good outcome. Luna: Which most people do. So it's a positive repositioning, even if it comes from a demographic challenge. Lucas: Exactly. It's not that the insurance industry is dying — it's that it has to evolve. And the companies that figure out how to price and distribute longevity products will be the ones that thrive in a graying world.